By Gwurld4026 
India’s Action Against Opioid Crisis: Drug Ban Explained
India has banned the manufacture and export of two highly addictive opioids, tapentadol and carisoprodol, following revelations of their illegal distribution in West African countries, including Nigeria, Ghana, and Côte d’Ivoire.
A BBC investigation uncovered that Mumbai-based Aveo Pharmaceuticals was exporting a harmful combination of these drugs, contributing to a public health crisis in the region. In response, Indian authorities have revoked the company’s licenses and seized their stock to prevent further distribution.
The combination of tapentadol, a potent opioid, and carisoprodol, a muscle relaxant banned in Europe due to its addictive properties, is not approved for medical use. Their misuse has led to severe health issues, including breathing difficulties, seizures, and fatal overdoses.
The Indian health ministry emphasized the need for stricter monitoring to prevent future illegal exports and to safeguard the country’s pharmaceutical reputation.